Management of barrett's esophagus with and without dysplasia

Scandinavian Journal of Gastroenterology, Supplement

Volumn 38, Issue 237, 2003, Pages 40-46

  Triadafilopoulos, George ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid and bile reflux; Barrett's esophagus; Dysplasia; Esophageal cancer; Gastroesophageal reflux disease (GERD)

Indexed keywords

ACETYLSALICYLIC ACID; ACID; AMINOLEVULINIC ACID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PHOTOSENSITIZING AGENT; PROTON PUMP INHIBITOR; ROFECOXIB; SODIUM PROFIMER; UNCLASSIFIED DRUG;

ACIDITY; ADENOCARCINOMA; ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; BILE; CANCER CELL; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; CONFERENCE PAPER; CRYOTHERAPY; DISEASE COURSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG SAFETY; DYSPLASIA; EXPOSURE; GASTROINTESTINAL REFLUX; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INHIBITION KINETICS; MEDICAL LITERATURE; METAPLASIA; METASTASIS POTENTIAL; MICROWAVE IRRADIATION; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT OUTCOME; ULTRASOUND THERAPY; BILE REFLUX; ESOPHAGUS; ESOPHAGUS TUMOR; GASTROESOPHAGEAL REFLUX; PATHOLOGY; REVIEW;

BARRETT ESOPHAGUS; BILE REFLUX; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 0038287999     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: 10.1080/00855910310001494     Document Type: Conference Paper

References (31)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 1991;265:1287-9.
2. Buttar NS, Falk GW. Pathogenesis of gastroesophageal reflux and Barrett esophagus. Mayo Clin Proc 2001;76:226-34.
3. DeMeester SR, Peters JH, DeMeester TR. Barrett's esophagus. Curr Probl Surg 2001;38:558-640.
4. Fitzgeral RC, Omary MB, Triadafilopoulos G. Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus. Am J Physiol 1998;38:G47-55.
5. Fitzgerald RC, Omary MB, Triadafilopoulos G. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 1996;98:212-8.
6. Fitzgerald RC, Triadafilopoulos G. Recent developments in the molecular characterization of Barrett's esophagus. Dig Dis Sci 1998;16:63-80.
7. Gillen P, Keeling P, Byrne P, et al. Implication of duodenogastric reflux in the pathogenesis of Barrett's esophagus. Br J Surg 1998;75:540-3.
8. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
9. Kandil HM, Tanner G, Smalley W, Halter S, Radhika A, Dubois RN. Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci 2001;46:758-9.
10. Kaur BS, Quatu-Lascar R, Omary MB, Triadafilopoulos G. Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion. Am Physiol (Gastrointest Liver Physiol) 2000;278:G1000-9.
11. Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus. Mayo Clin Proc 2001;76:438-46.
12. Lagergren J, Bergstrom R, Lingren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
13. Levine D, Haggitt R, Blount P, Rabinovitch P, Rusch V, Reid B. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
14. Locke GR, Talley N, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux. A population-based study in Olmstead County, Minnesota. Gastroenterology 1997;112:1448-56.
15. Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarnoma sequence. Am J Gastroenterol 2001;96:990-6.
16. Neumann C, Iqbal T, Cooper B. Long-term continuous omeprazole treatment of patients with Barrett's esophagus. Aliment Pharmacol Ther 1995;9:451-4.
17. Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, et al. Endoscopic regression of Barrett's oesophagus during omeprazole therapy: a randomized double blind study. Gut 1999;45:489-94.
18. Quatu-Lascar R, Fitzgerald RV, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 1999;117:327-35.
19. Richter JE. Importance of bile reflux in Barrett's esophagus. Dig Dis:2000-200118:208-16.
20. Sampliner RE, and the practice parameters committee of the American College of Gastroenterology., Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 1998;93:1028-32.
21. Sarr M, Hamilton S, Marrone G, Cameron J. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 1985:149:187-93.
22. Souza RF, Morales CP, Spechler SJ. A conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's esophagus. Aliment Pharmacol Ther 2001;15:1087-100.
23. Souza RF, Shewmake K, Terada LS, Spechler SJ. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002;122:299-307.
24. Spechler S, Goyal R. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110:614-21.
25. Spechler SJ. Barrett's esophagus. N Engl J Med 2002;346:836-42.
26. Shirvani VN, Quatu-Lascar R, Kaur BS, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology 2000;118:487-96.
27. Triadafilopoulos G. Acid and bile reflux in Barrett's esophagus: a tale of two evils [editorial]. Gastroenterology 2001; 121:1502-6.
28. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1994;117:699-704.
29. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192-9.
30. Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998;58:2929-34.
31. Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001;121:1391-9.